INS and type 2 diabetes mellitus: In contrast to T1DM, the main therapeutic strategy for T2DM is using anti-hyperglycemic agents that work by inducing insulin sensitivity (glitazones), reducing glucose production in liver (metformin) or enhancing insulin release by pancreatic β cells (sulfonylureas) [7].